Phase II feasibility trial incorporating bevacizumab into dose dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104) Meeting Abstract
| Authors: | Miller, K. D.; Oneill, A.; Perez, E. A.; Seidman, A. D.; Sledge, G. W. |
| Abstract Title: | Phase II feasibility trial incorporating bevacizumab into dose dense doxorubicin and cyclophosphamide followed by paclitaxel in patients with lymph node positive breast cancer: A trial of the Eastern Cooperative Oncology Group (E2104) |
| Meeting Title: | 30th Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Breast Cancer Research and Treatment |
| Volume: | 106 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2007 Dec 13-16 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0167-6806 |
| Publisher: | Springer |
| Date Published: | 2007-12-01 |
| Start Page: | S147 |
| Language: | English |
| ACCESSION: | WOS:000251398500409 |
| PROVIDER: | wos |
| PUBMED: | 17957466 |
| DOI: | 10.1007/s10549-007-9793-3 |
| Notes: | --- - Meeting Abstract: 3063 - 30th Annual San Antonio Breast Cancer Symposium - DEC 13-16, 2007 - San Antonio, TX - "1" - "Source: Wos" |
